In a recent webinar, we discussed the recent increase in government enforcement against healthcare providers under the Controlled Substances Act (CSA) that has occurred over the past year.

In addition to steep penalties, controlled substances violations may trigger patient care concerns, generate public relations challenges, carry years-long oversight and reporting requirements, and create enterprise risk.

Topics covered include:

  • Recent government enforcement settlements under the CSA, trends, and priorities.
  • The impact of regulatory changes and guidance issued by the U.S. Drug Enforcement Administration (DEA) on healthcare providers.
  • Best practices for responding to diversion events and unannounced DEA inspections.
  • Tools to mitigate risk and ensure compliance.

Click here to access this webinar.

Who Should Attend?

  • In-house legal counsel
  • Compliance officers
  • Privacy officers
  • C-level executives, consultants and principals


Tennessee CLE
This webinar is approved for one hour of General Tennessee CLE credit. Please provide your BPR number upon registration for Bass, Berry & Sims to report your participation to the Tennessee CLE Commission following the webinar. 

Other State CLE 
Bass, Berry & Sims does not seek direct accreditation from states outside of Tennessee, but some states allow attorneys to earn credit through reciprocity or self-submission. Certificates of completion and other common supporting documents will be provided for use in jurisdictions outside of Tennessee.


Submit your questions to Kendall Betts.